Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial

IMPORTANCE: It is unknown whether olanzapine combined with triplet antemetic therapy is effective for all patients undergoing highly emetogenic chemotherapy. A secondary analysis of randomized clinical trials using olanzapine may provide insight into the effectiveness of olanzapine for chemotherapy-...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Masakazu, Yamaguchi, Takuhiro, Fujita, Yukiyoshi, Nishimura, Tomoyasu, Kitagawa, Koichi, Inui, Naoki, Hirano, Katsuya, Sakata, Yukio, Iihara, Hirotoshi, Shibuya, Yuichi, Suzuki, Kenichi, Shibata, Kazuhiko, Hori, Kensuke, Daga, Haruko, Nakayama, Toshiaki, Sakata, Yasuhiko, Takahashi, Takako Yanai, Zenda, Sadamoto, Hashimoto, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155068/
https://www.ncbi.nlm.nih.gov/pubmed/37129897
http://dx.doi.org/10.1001/jamanetworkopen.2023.10894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155068/
https://www.ncbi.nlm.nih.gov/pubmed/37129897
http://dx.doi.org/10.1001/jamanetworkopen.2023.10894

Ejemplares similares